enVVeno Medical Corp Sustainability Reports
A late clinical-stage medical device company focused on developing bioprosthetic (tissue-based) solutions for deep venous disease, specifically the VenoValve and enVVe systems.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2022 to 2024
Company Profile
A late clinical-stage medical device company focused on developing bioprosthetic (tissue-based) solutions for deep venous disease, specifically the VenoValve and enVVe systems.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
